Bismuth-Based Quadruple Therapy versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial

BACKGROUND/AIMS: Clarithromycin resistance is a main factor for treatment failure in the context of Helicobacter pylori infection. However, the treatment regimen for clarithromycin-resistant H. pylori infection has not yet been determined. We aimed to compare the efficacy and cost-effectiveness of 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Seung In, Lim, Hyun, Bang, Chang Seok, Yang, Young Joo, Baik, Gwang Ho, Lee, Sang Pyo, Jang, Hyun Joo, Kae, Sea Hyub, Kim, Jinseob, Kim, Hak Yang, Shin, Woon Geon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474493/
https://www.ncbi.nlm.nih.gov/pubmed/35145043
http://dx.doi.org/10.5009/gnl210365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474493/
https://www.ncbi.nlm.nih.gov/pubmed/35145043
http://dx.doi.org/10.5009/gnl210365

Ejemplares similares